Equillium, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Equillium, Inc. - overview
Established
2017
Location
La Jolla, CA, US
Primary Industry
Biotechnology
About
Founded in 2017 and based in California, US, Equillium, Inc. operates as a biotechnology company that develops products to treat severe autoimmune and inflammatory disorders with high unmet medical needs.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Website
www.equilliumbio.com
Total Amount Raised
Subscriber access only
Equillium, Inc. - timeline of key events
Equillium, Inc. - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - |
| EBITDA (USD) | (8,609,485) | (26,639,000) | (29,139,000) | - | - | - |
| Operating Income (USD) | (8,615,587) | (26,727,000) | (29,548,000) | - | - | - |
| Operating Margin | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - |
| NET Income (USD) | (13,250,475) | (25,600,000) | (29,813,000) | - | - | - |
| % Net Margin | - | - | - | - | - | - |
Equillium, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.